Ultrasound Device Offers an Alternative to Analgesics
By HospiMedica International staff writers Posted on 24 Jun 2020 |
Image: The sam applied to Achilles tendon injury to stimulate collagen-matrix rebuilding (Photo courtesy of ZetrOZ Systems)
A long-duration acoustic device offers physicians an alternative solution to pain medication and surgery for their patients.
The ZetrOZ Systems (Trumbull, CT, USA) sustained acoustic medicine (sam) is a drug free, wearable, non-invasive device that uses patented ultra-low impedance miniaturization technology to deliver long duration, low intensity ultrasound therapy. The technology, called OZ Inside, optimizes electro-acoustic signal conduction to achieve peak efficiencies across the entire spectrum of ultrasound outputs, which has been clinically proven to aid in the treatment of tendon, muscle, and joint injuries, by accelerating the body’s natural healing process.
The low intensity ultrasonic-waves penetrate up to five centimeters into the tissue, covering a treatment area about the diameter of a baseball for up to four hours per day. The continuous ultrasound wave is emitted at a frequency of 3MHz, a power level of 0.65 watts, and an energy density of 0.132 watts/cm2 per applicator, all controlled by smart treatment monitoring. The system comes with two hypoallergenic 3M gel-capture patches with improved wear performance and patented seals.
“We want physicians and orthopedic surgeons to know they are not limited in the options they can offer patients. sam gives them a viable, convenient alternative to prescribing drugs or putting patients under the knife,” said George Lewis, CEO of ZetrOZ Systems. “While sam is technologically sophisticated, it is also easy to use and apply, making it the perfect choice for home application by patients. The solution is convenient, as patients can engage in most activities while wearing it.”
Ultrasound is one of the most commonly used modality by physical therapists and athletic trainers, with several clinical applications, including aiding the inflammatory response to injury, superficial wound, bone, and connective tissue healing, assessing stress fractures, treating pitting edema, reducing muscle spasm, reducing pain, restoring range of motion lost due to scar tissue and/or joint contracture, and treating chronic inflammation.
Related Links:
ZetrOZ Systems
The ZetrOZ Systems (Trumbull, CT, USA) sustained acoustic medicine (sam) is a drug free, wearable, non-invasive device that uses patented ultra-low impedance miniaturization technology to deliver long duration, low intensity ultrasound therapy. The technology, called OZ Inside, optimizes electro-acoustic signal conduction to achieve peak efficiencies across the entire spectrum of ultrasound outputs, which has been clinically proven to aid in the treatment of tendon, muscle, and joint injuries, by accelerating the body’s natural healing process.
The low intensity ultrasonic-waves penetrate up to five centimeters into the tissue, covering a treatment area about the diameter of a baseball for up to four hours per day. The continuous ultrasound wave is emitted at a frequency of 3MHz, a power level of 0.65 watts, and an energy density of 0.132 watts/cm2 per applicator, all controlled by smart treatment monitoring. The system comes with two hypoallergenic 3M gel-capture patches with improved wear performance and patented seals.
“We want physicians and orthopedic surgeons to know they are not limited in the options they can offer patients. sam gives them a viable, convenient alternative to prescribing drugs or putting patients under the knife,” said George Lewis, CEO of ZetrOZ Systems. “While sam is technologically sophisticated, it is also easy to use and apply, making it the perfect choice for home application by patients. The solution is convenient, as patients can engage in most activities while wearing it.”
Ultrasound is one of the most commonly used modality by physical therapists and athletic trainers, with several clinical applications, including aiding the inflammatory response to injury, superficial wound, bone, and connective tissue healing, assessing stress fractures, treating pitting edema, reducing muscle spasm, reducing pain, restoring range of motion lost due to scar tissue and/or joint contracture, and treating chronic inflammation.
Related Links:
ZetrOZ Systems
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergecny Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure